Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study.
Laurine DiazBenjamin JauzelonAnne-Charlotte DilliesCosette Le SouderJean-Luc FaillieAlexandre Thibault Jacques MariaPascale PalassinPublished in: Journal of clinical medicine (2023)
Clinicians should be aware of the potential risk of ICI-related HLH to improve the early diagnosis of this rare immune-related adverse event.